|Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production|
M Umezu-Goto, Y Kishi, A Taira, K Hama, N Dohmae, K Takio, T Yamori, ...
J cell biol 158 (2), 227-233, 2002
|Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors|
R Hoshino, Y Chatani, T Yamori, T Tsuruo, H Oka, O Yoshida, Y Shimada, ...
Oncogene 18 (3), 813, 1999
|Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor|
S Yaguchi, Y Fukui, I Koshimizu, H Yoshimi, T Matsuno, H Gouda, ...
Journal of the National Cancer Institute 98 (8), 545-556, 2006
|Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide|
L Yang, T Mashima, S Sato, M Mochizuki, H Sakamoto, T Yamori, ...
Cancer research 63 (4), 831-837, 2003
|Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma|
H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi
Cancer: Interdisciplinary International Journal of the American Cancer …, 2001
|Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel|
T Yamori, A Matsunaga, S Sato, K Yamazaki, A Komi, K Ishizu, I Mita, ...
Cancer research 59 (16), 4042-4049, 1999
|Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1|
K Hama, J Aoki, M Fukaya, Y Kishi, T Sakai, R Suzuki, H Ohta, T Yamori, ...
Journal of Biological Chemistry 279 (17), 17634-17639, 2004
|An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines|
S Dan, T Tsunoda, O Kitahara, R Yanagawa, H Zembutsu, T Katagiri, ...
Cancer Research 62 (4), 1139-1147, 2002
|A human IAP-family gene, apollon, expressed in human brain cancer cells|
Z Chen, M Naito, S Hori, T Mashima, T Yamori, T Tsuruo
Biochemical and biophysical research communications 264 (3), 847-854, 1999
|Development of cDNA microarray for expression profiling of estrogen responsive genes|
A Inoue, N Yoshida, Y Omoto, S Oguchi, T Yamori, R Kiyama, S Hayashi
Journal of Molecular Endocrinology 29 (2), 175-192, 2002
|Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid|
Y Kishi, S Okudaira, M Tanaka, K Hama, D Shida, J Kitayama, T Yamori, ...
Journal of Biological Chemistry 281 (25), 17492-17500, 2006
|Blockade of the stromal cell–derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor–independent manner|
B Guleng, K Tateishi, M Ohta, F Kanai, A Jazag, H Ijichi, Y Tanaka, ...
Cancer research 65 (13), 5864-5871, 2005
|Expression, function, and clinical implications of the estrogen receptor β in human lung cancers|
Y Omoto, Y Kobayashi, K Nishida, E Tsuchiya, H Eguchi, K Nakagawa, ...
Biochemical and biophysical research communications 285 (2), 340-347, 2001
|Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma|
SD Hoff, Y Matsushita, DM Ota, KR Cleary, T Yamori, S Hakomori, ...
Cancer research 49 (24 Part 1), 6883-6888, 1989
|Effect on tumor cells of blocking survival response to glucose deprivation|
HR Park, A Tomida, S Sato, Y Tsukumo, J Yun, T Yamori, Y Hayakawa, ...
Journal of the National Cancer Institute 96 (17), 1300-1310, 2004
|Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting|
M Murakami, H Cabral, Y Matsumoto, S Wu, MR Kano, T Yamori, ...
Science translational medicine 3 (64), 64ra2-64ra2, 2011
|Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity|
Y Komatsu, K Tomizaki, M Tsukamoto, T Kato, N Nishino, S Sato, ...
Cancer Research 61 (11), 4459-4466, 2001
|Phosphatidylinositol 3‐kinase inhibitors: promising drug candidates for cancer therapy|
D Kong, T Yamori
Cancer science 99 (9), 1734-1740, 2008
|Insulin and insulin‐like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26|
M Koenuma, T Yamori, T Tsuruo
Japanese journal of cancer research 80 (1), 51-58, 1989
|Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1)|
A Komuro, T Imamura, M Saitoh, Y Yoshida, T Yamori, K Miyazono, ...
Oncogene 23 (41), 6914, 2004